Cargando…

Successful Treatment of Pseudoseptic Arthritis Contained Massive Purulent Fluid with Adalimumab in Rheumatoid Arthritis

Detalles Bibliográficos
Autores principales:	Chung, Chong Hyuk, Lee, Myeung Su, Lee, Chang-Hoon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Chonnam National University Medical School 2020
Materias:	Images in Clinical Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520364/ https://www.ncbi.nlm.nih.gov/pubmed/33014766 http://dx.doi.org/10.4068/cmj.2020.56.3.214

Ejemplares similares

Pseudoseptic Arthritis in a Patient With Psoriasis
por: Verdecia, Jorge, et al.
Publicado: (2021)

Pseudoseptic Arthritis: An Initial Presentation of Underlying Psoriatic Arthritis
por: Paul, Prodip, et al.
Publicado: (2021)

Pseudoseptic Arthritis: A Case Series and Review of the Literature
por: Oppermann, Brian P., et al.
Publicado: (2011)

Health-related Quality of Life Outcomes of Adalimumab for Patients With Rheumatoid Arthritis in Korea
por: Lee, Myeung-su, et al.
Publicado: (2021)

Late hemorrhagic pseudoseptic arthritis encountered during total knee arthroplasty due to hyaluronic acid viscosupplementation
por: Korsh, Jeremy M., et al.
Publicado: (2016)

Cost-effectiveness of adalimumab for rheumatoid arthritis in Germany
por: Gissel, C., et al.
Publicado: (2016)

Long-term treatment of rheumatoid arthritis with adalimumab
por: Murdaca, Giuseppe, et al.
Publicado: (2013)

Purulent Arthritis Complicating Smallpox
por: Wallace, E. H., et al.
Publicado: (1939)

Effect of adalimumab on neutrophil function in patients with rheumatoid arthritis
por: Capsoni, Franco, et al.
Publicado: (2005)

Review of Biosimilar Trials and Data on Adalimumab in Rheumatoid Arthritis
por: Zhao, Sizheng, et al.
Publicado: (2018)

Sweet’s Syndrome in a Patient With Seropositive Rheumatoid Arthritis After Starting Adalimumab: Is Sweet’s Syndrome Related to Rheumatoid Arthritis or Is It the Paradoxical Effect of Adalimumab?
por: Paul, Prodip, et al.
Publicado: (2021)

A case of purulent gonococcal arthritis
por: Vidaurrazaga, Monica M., et al.
Publicado: (2019)

Successful Treatment of Rituximab-Associated Palmoplantar Pustulosis With Apremilast in a Patient With Seropositive Rheumatoid Arthritis
por: Haller, Christoph, et al.
Publicado: (2021)

Effectiveness of dose reduction of etanercept and adalimumab in patients with rheumatoid arthritis
por: Martínez-Pérez, Rosalía, et al.
Publicado: (2011)

Monocyte migration to the synovium in rheumatoid arthritis patients treated with adalimumab
por: Herenius, M M J, et al.
Publicado: (2011)

Switching from adalimumab to tofacitinib in the treatment of patients with rheumatoid arthritis
por: Genovese, Mark C., et al.
Publicado: (2016)

Regulatory T cells as a biomarker for response to adalimumab in rheumatoid arthritis
por: Nguyen, Dao X., et al.
Publicado: (2018)

Long-Term Effectiveness of Adalimumab in Patients with Rheumatoid Arthritis: An Observational Analysis from the Corrona Rheumatoid Arthritis Registry
por: Pappas, Dimitrios A., et al.
Publicado: (2017)

Adalimumab in the treatment of arthritis
por: Mease, Philip J
Publicado: (2007)

Two cases of acute pneumococcal purulent arthritis
por: Seki, Masafumi, et al.
Publicado: (2018)

Successful adalimumab graded challenge after allergic delayed reaction to golimumab in a woman with rheumatoid arthritis
por: Rivolta, Federica, et al.
Publicado: (2023)

Development of Rheumatoid Nodules after Anti-Tumor Necrosis Factor-α Treatment with Adalimumab for Rheumatoid Arthritis
por: Shin, Sungsik, et al.
Publicado: (2016)

Opera-Glass Hand in a Patient With Rheumatoid Arthritis
por: Yin, Yufeng, et al.
Publicado: (2016)

Polyarteritis Nodosa: Gangrene in a Rheumatoid Arthritis Patient
por: Koshida, Yuki, et al.
Publicado: (2023)

Monocyte populations as markers of response to adalimumab plus MTX in rheumatoid arthritis
por: Chara, Luis, et al.
Publicado: (2012)

Digital Vasculitis in a Patient with Rheumatoid Arthritis Responded Well to Adalimumab
por: Kobak, Senol, et al.
Publicado: (2014)

Adalimumab regulates intracellular TNFα production in patients with rheumatoid arthritis
por: Zamora-Atenza, Carlos, et al.
Publicado: (2014)

Reply to: Need for improvements in reported cost-effectiveness of adalimumab in rheumatoid arthritis
por: Gissel, C., et al.
Publicado: (2017)

Beyond the joints in rheumatoid arthritis: Effects of adalimumab on hematologic and lipid indices
por: Sakthiswary, R., et al.
Publicado: (2012)

Comparative Effectiveness of Adalimumab vs Tofacitinib in Patients With Rheumatoid Arthritis in Australia
por: Deakin, Claire T., et al.
Publicado: (2023)

Charcot arthropathy due to rheumatoid arthritis
por: Uslu, Sadettin
Publicado: (2021)

Popeye deformity in rheumatoid arthritis
por: Gupta, R, et al.
Publicado: (2016)

Upper thoracic vertebral abnormalities in a patient with rheumatoid arthritis
por: Son, Chang-Nam, et al.
Publicado: (2014)

Successful use of adalimumab in immune checkpoint inhibitor-associated inflammatory arthritis
por: Oke, Anuoluwapo R, et al.
Publicado: (2018)

Adalimumab-induced acute interstitial lung disease in a patient with rheumatoid arthritis
por: Dias, Olívia Meira, et al.
Publicado: (2014)

Clinical and economic efficiency to reduce dose etanercept and adalimumab in patients with rheumatoid arthritis
por: Martínez-Pérez, Rosalía, et al.
Publicado: (2012)

Effects of Treatment with Adalimumab on Blood Lipid Levels and Atherosclerosis in Patients with Rheumatoid Arthritis
por: Bergström, Ulf, et al.
Publicado: (2018)

Treatment of lichen planopilaris with adalimumab in a patient with hidradenitis suppurativa and rheumatoid arthritis
por: Alam, Maryam Shayesteh, et al.
Publicado: (2020)

Efficacy and Safety of Adalimumab Biosimilars: Current Critical Clinical Data in Rheumatoid Arthritis
por: Lu, XiaoQin, et al.
Publicado: (2021)

Adalimumab Biosimilars in the Treatment of Rheumatoid Arthritis: A Systematic Review of the Evidence for Biosimilarity
por: Huizinga, Tom W. J., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rdn2snmtb4strsbh92dsfpqjm5